Children aged 12 and over are now eligible to receive the Moderna mRNA vaccine for immunisation against the CCP virus after Australia’s drug regulator granted provisional approval.
The Therapeutic Goods Administration (TGA) said on Sept. 4 the decision had been fast-tracked, with the regulator saying the vaccine met its safety standards for use in Australia.